RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 958 - per page Next page
Order by
Collagen-based dressings for wound management More
25 and 50 mg diclofenac K film coated immediate release tablets More
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Conception aid, fertility cup More
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
25mg dosage strenght for the OTC market in film coated tablets More
Collagen-based biodegradable matrices for localized drug delivery More
Novel patent pending in dermatology: combination of a well known topical antibiotic with a topical steroid indicated for skin infections with inflammatory process More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Displaying 1..10 of 958 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us